PAG
INMB icon

Private Advisor Group’s INmune Bio INMB Stock Holding History

Private Advisor Group’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-675
Closed -$4K – 2489
2020
Q2 		$4K Buy
+675
New +$3.4K ﹤0.01% 3338

Other funds holding INMB

GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Private Advisor Group's INMB Position: Q3 2020 in Review

Private Advisor Group sold out of INmune Bio (INMB) in Q3 2020, closing a stake of 675 shares — an estimated $4K sold.

Private Advisor Group first reported a position in INMB in Q2 2020 and held it in 1 quarter. The position peaked at $4K in Q2 2020. 28 funds tracked by Wall St. Rank hold INMB as of Q3 2020.

  • Private Advisor Group reported no remaining INmune Bio position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 675 INmune Bio shares in Q3 2020, an estimated $4K.
  • Private Advisor Group first reported a position in INmune Bio in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's INmune Bio position peaked at $4K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held INmune Bio as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.